H.C. Wainwright Reiterates a Hold Rating on Motif Bio plc (MTFB)


H.C. Wainwright analyst Ram Selvaraju reiterated a Hold rating on Motif Bio plc (MTFB) today. The company’s shares closed yesterday at $1.61, close to its 52-week low of $1.54.

According to TipRanks.com, Selvaraju has currently no stars on a ranking scale of 0-5 stars, with an average return of -4.1% and a 36.6% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Biospecifics Technologies Corp, EyePoint Pharmaceuticals Inc, and Bausch Health Companies Inc.

The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Motif Bio plc.

See today’s analyst top recommended stocks >>

The company has a one-year high of $11.50 and a one-year low of $1.54. Currently, Motif Bio plc has an average volume of 171.6K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Motif Bio Plc is a clinical stage biopharmaceutical company which develops novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It pipeline of antibiotics includes iclaprim, and MTF-001, a preclinical program to design a dihydrofolate reductase inhibitor (DHFRi).

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts